Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema

Relhan, Nidhi; Flynn, Harry, W., Jr

Current Opinion in Ophthalmology: May 2017 - Volume 28 - Issue 3 - p 205–212
doi: 10.1097/ICU.0000000000000362
RETINAL, VITREOUS AND MACULAR DISORDERS: Edited by Brandon G. Busbee and John W. Kitchens
Buy
SDC
Editor's Choice

Purpose of review To provide an historical review of the Early Treatment Diabetic Retinopathy Study (ETDRS) in the management of diabetic macular edema (DME), and to discuss its relevance to the management of DME.

Recent findings The ETDRS reported that argon laser treatment is beneficial in the management of ‘clinically significant’ DME. The study provided guidelines for the treatment with focal and/or grid laser based on fluorescein angiographic patterns. In today's world, with the advent of optical coherence tomography, ‘clinically significant’ DME is now classified into center-involved DME (CI DME) and noncenter-involved DME (non-CI DME). Modified ETDRS focal/grid laser photocoagulation has been utilized in more recent clinical trials [diabetic retinopathy clinical research (DRCR) Protocols I and T] in combination with intravitreal injections.

Summary The ETDRS provided outcomes data for DME, both untreated and following laser therapy. In the management of patients with DME today, the modified ETDRS focal/grid laser photocoagulation treatments remain relevant in combination with anti-vascular endothelial growth factor (anti-VEGF) therapy as ophthalmologists and their patients choose how best to treat DME. Ongoing studies in eyes with DME, nonproliferative diabetic retinopathy, and good visual acuity will help further define the place of modified ETDRS focal/grid laser in the treatment of DME.

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA

Correspondence to Harry W. Flynn Jr, MD, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine 900 NW, 17th Street, Miami, FL 33136, USA. Tel: +1 305 326 6118; fax: +1 305 326 6417; e-mail: hflynn@med.miami.edu

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.